UPDATE: Piper Jaffray Lowering Price Target On Masimo

Piper Jaffray is out with a research report on Masimo Corporation MASI and is lowering its price target to $36 from $38, but is keeping its Overweight rating on shares. In a note to clients, Piper Jaffray writes, "Masimo reported mixed 2Q11 results, with overall revenue missing our and Street expectations, with in-line EPS. Management attributed soft Rainbow results to global uncertainly, but maintained segment guidance of $40M-$50M on the prospects for a 3Q military order. Consistent with an emerging cap-ex pause, driver placements were lower than our expectations (37,300 vs. PJC: 38,208), although up yoy. EPS of $0.28 was in-line with our $0.28 estimate, with a $0.02 tax benefit. We maintain our Overweight rating on MASI shares and are lowering our target to $36 (was $38 price target)." Shares of MASI gained $1.83 yesterday to close at $25.01, a gain of 7.89%.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareHealth Care EquipmentPiper Jaffray
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!